TROYANOSYVIRUS
Zuruck zu CVEs

CVE-2022-32917

HIGHCISA KEV
7.8

Beschreibung

The issue was addressed with improved bounds checks. This issue is fixed in macOS Monterey 12.6, iOS 15.7 and iPadOS 15.7, iOS 16, macOS Big Sur 11.7. An application may be able to execute arbitrary code with kernel privileges. Apple is aware of a report that this issue may have been actively exploited..

CVE Details

CVSS v3.1 Bewertung7.8
SchweregradHIGH
CVSS VektorCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
AngriffsvektorLOCAL
KomplexitatLOW
Erforderliche PrivilegienLOW
BenutzerinteraktionNONE
Veroffentlicht9/20/2022
Zuletzt geandert10/23/2025
Quellekev
Honeypot-Sichtungen0

CISA KEV

HerstellerApple
ProduktiOS, iPadOS, and macOS
SchwachstellennameApple iOS, iPadOS, and macOS Remote Code Execution Vulnerability
KEV Aufnahmedatum2022-09-14
Behebungsfrist2022-10-05
Ransomware-NutzungUnknown

Betroffene Produkte

apple:ipadosapple:iphone_osapple:macos

Schwachen (CWE)

CWE-787CWE-787

Referenzen

https://support.apple.com/en-us/HT213443(product-security@apple.com)
https://support.apple.com/en-us/HT213444(product-security@apple.com)
https://support.apple.com/en-us/HT213445(product-security@apple.com)
https://support.apple.com/en-us/HT213446(product-security@apple.com)
http://seclists.org/fulldisclosure/2022/Oct/39(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2022/Oct/40(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2022/Oct/43(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2022/Oct/45(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/en-us/HT213443(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/en-us/HT213444(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/en-us/HT213445(af854a3a-2127-422b-91ae-364da2661108)
https://support.apple.com/en-us/HT213446(af854a3a-2127-422b-91ae-364da2661108)

IOC Korrelationen

Keine Korrelationen erfasst

This product uses data from the NVD API but is not endorsed or certified by the NVD.